Sort by
Keyphrases
Antitrypsin
100%
Binding Site
100%
Elastase
100%
Anti-inflammatory Properties
100%
Point mutation
100%
Anti-inflammatory Activity
30%
Inflammatory Profile
20%
Supernatant
10%
Protease
10%
Sequence Specificity
10%
Recombinant
10%
Peritoneal Macrophages
10%
Peritonitis
10%
Recombinant Human
10%
Nave
10%
Protrusion
10%
Amino Acids
10%
Anti-elastase Activity
10%
LPS-induced Inflammation
10%
Elastase Inhibition
10%
Proteasome Inhibition
10%
Pharmacokinetics
10%
Purified Proteins
10%
Reactive Center Loop
10%
Primary Peritoneal
10%
Mouse Bone Marrow
10%
Bone Marrow-derived Macrophages
10%
Recombinant Variants
10%
Long-circulating
10%
His-tag
10%
RAW264.7 Cells
10%
Neutrophil Elastase Inhibitor
10%
Biochemistry, Genetics and Molecular Biology
Binding Site
100%
Elastase
100%
Point Mutation
100%
Anti-Inflammatory
100%
Antiinflammatory Activity
60%
Tumor Necrosis Factor
40%
Macrophage
40%
Wild Type
40%
Dynamics
20%
Transcription
20%
Pharmacokinetics
20%
Neutrophil Elastase
20%
Proteinase Inhibition
20%
Recombinant
20%
Amino Acids
20%
Protease
20%
Immunology and Microbiology
Antiinflammatory Activity
100%
Binding Site
100%
Point Mutation
100%
Tumor Necrosis Factor
66%
Wild Type
66%
Dynamics
33%
Neutrophil
33%
Peritonitis
33%
Proteinase Inhibition
33%
Pharmacokinetics
33%
Bone Marrow-Derived Macrophage
33%
Amino Acid
33%
Peritoneal Macrophage
33%
In Vitro
33%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Trypsin Inhibitor
100%
Binding Site
100%
Elastase
100%
Tumor Necrosis Factor
20%
Proteinase
20%
Amino Acid
10%
Peritonitis
10%
Recombinant
10%
Polyhistidine Tag
10%
Leukocyte Elastase Inhibitor
10%
Pharmacokinetics
10%